Predicted to enable CCR6 chemokine receptor binding activity and chemoattractant activity. Acts upstream of or within defense response to Gram-negative bacterium. Predicted to be located in extracellular region. Predicted to be active in extracellular space. Orthologous to human DEFB4B (defensin beta 4B). [provided by Alliance of Genome Resources, Apr 2022]